IMMUNE DESIGN CORP. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of premium/discount on investments
Impairment of inventory
Stock-based compensation
Revaluation of convertible preferred stock warrant liability
Other
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses
Restricted cash
Other assets
Security deposit
Accounts payable
Accrued liabilities
Accrued litigation-related settlement
Deferred revenue
Deferred rent and other noncurrent liabilities
Net cash used in operating activities

Investing activities
Purchases of property and equipment
Proceeds from the sale of property and equipment
Purchases of short-term investments
Maturities of short-term investments
Net cash provided by (used in) investing activities

Financing activities
Issuance of common stock in public offering, net of offering costs
Proceeds from exercise of preferred stock warrants
Proceeds from exercise of stock options
Proceeds from issuances of common stock under stock-based compensation plans
Proceeds from sale of convertible preferred stock, net of cash paid for issuance costs
Proceeds from sale of convertible preferred stock warrants
Net cash provided by financing activities

Cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash, cash equivalents and restricted cash, beginning of year
Cash, cash equivalents and restricted cash, end of year
Supplemental cash flow information
Unpaid stock offering costs
Cash and cash equivalents
Conversion into shares of common stock
Conversion of shares of preferred stock into shares of common stock
Conversion of preferred stock warrants into shares of common stock
Restricted cash
Security deposit

Comments